Indexed logomarkindexed.vc

Definium Therapeutics, Inc. Common Shares

IPO

Definium Therapeutics, Inc. Common Shares is a biotech company in New York, United States, founded in 2019. It has raised $371.0M across 4 rounds, most recently a $225.0M Corporate Round in August 2023.

Definium Therapeutics (Formerly MindMed) | Psychedelic Medicine

Biotech
Healthcare
Headquarters
New York, New York
Employees
11–50
Founded
2019
Business Model
B2B
Website
definiumtx.com
Total Funding
$371.0M
Last Round
$225.0M Corporate RoundAug 2023
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds for this company. The full record is or through the API.

About

Definium Therapeutics (formerly MindMed, founded in 2019) is a clinical-stage biopharmaceutical company headquartered in New York developing psychedelic-inspired medicines for psychiatric and neurological disorders. Its lead candidate, DT120 ODT, has received FDA Breakthrough Therapy Designation for generalized anxiety disorder and is in Phase 3 trials for both GAD and major depressive disorder. The company rebranded from MindMed to Definium Therapeutics in January 2026.

Summary

It lists 11–50 employees. It has raised $371.0M in total across 4 rounds, most recently a $225.0M Corporate Round in Aug 2023.

LinkedInX (Twitter)

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundAug 2023
$225.0M

Sign up to see all 5 events

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Definium Therapeutics, Inc. Common Shares on Indexed.vc
<a href="https://indexed.vc/companies/definium-therapeutics-inc-common-shares"><img src="https://indexed.vc/api/badge/company/definium-therapeutics-inc-common-shares" alt="Definium Therapeutics, Inc. Common Shares on Indexed.vc" width="260" height="76" /></a>